OBJECTIVE: To evaluate the feasibility and safety of a home-based exercise programme for people with Alzheimer's disease, and to provide preliminary evidence of programme effectiveness in improving balance and mobility and reducing falls risk. DESIGN: A randomized controlled trial. SETTING: Community. PARTICIPANTS: Forty people with mild to moderate Alzheimer's disease (mean age 81.9, SD 5.72; 62.5% female). INTERVENTIONS: Participants were randomized to a six-month home-based individually tailored balance, strengthening and walking exercise programme (physiotherapist) or a six-month home-based education programme (control) (occupational therapist). Both programmes provided six home-visits and five follow-up phone calls. MAIN MEASURES: Balance, mobility, falls and falls risk were measured at baseline and programme completion. Intention-to-treat analysis using a generalized linear model with group allocation as a predictor variable was performed to evaluate programme effectiveness. Feasibility and adverse events were systematically recorded at each contact. RESULTS: Fifty-eight per cent of the exercise group finished the programme, completing an average of 83% of prescribed sessions, with no adverse events reported. Functional Reach improved significantly (P = 0.002) in the exercise group (mean (SD), 2.28 (4.36)) compared to the control group (-2.99 (4.87)). Significant improvement was also observed for the Falls Risk for Older People - Community score (P = 0.008) and trends for improvement on several other balance, mobility, falls and falls risk measures for the exercise group compared to the control group. CONCLUSIONS: The exercise programme was feasible and safe and may help improve balance and mobility performance and reduce falls risk in people with Alzheimer's disease.
RCT Entities:
OBJECTIVE: To evaluate the feasibility and safety of a home-based exercise programme for people with Alzheimer's disease, and to provide preliminary evidence of programme effectiveness in improving balance and mobility and reducing falls risk. DESIGN: A randomized controlled trial. SETTING: Community. PARTICIPANTS: Forty people with mild to moderate Alzheimer's disease (mean age 81.9, SD 5.72; 62.5% female). INTERVENTIONS:Participants were randomized to a six-month home-based individually tailored balance, strengthening and walking exercise programme (physiotherapist) or a six-month home-based education programme (control) (occupational therapist). Both programmes provided six home-visits and five follow-up phone calls. MAIN MEASURES: Balance, mobility, falls and falls risk were measured at baseline and programme completion. Intention-to-treat analysis using a generalized linear model with group allocation as a predictor variable was performed to evaluate programme effectiveness. Feasibility and adverse events were systematically recorded at each contact. RESULTS: Fifty-eight per cent of the exercise group finished the programme, completing an average of 83% of prescribed sessions, with no adverse events reported. Functional Reach improved significantly (P = 0.002) in the exercise group (mean (SD), 2.28 (4.36)) compared to the control group (-2.99 (4.87)). Significant improvement was also observed for the Falls Risk for Older People - Community score (P = 0.008) and trends for improvement on several other balance, mobility, falls and falls risk measures for the exercise group compared to the control group. CONCLUSIONS: The exercise programme was feasible and safe and may help improve balance and mobility performance and reduce falls risk in people with Alzheimer's disease.
Authors: Lauren T Ptomey; Eric D Vidoni; Esteban Montenegro-Montenegro; Michael A Thompson; Joseph R Sherman; Anna M Gorczyca; Jerry L Greene; Richard A Washburn; Joseph E Donnelly Journal: J Aging Phys Act Date: 2019-09-01 Impact factor: 1.961
Authors: Lauren T Ptomey; Amanda N Szabo-Reed; Eric D Vidoni; Richard A Washburn; Anna M Gorczyca; Todd D Little; Jaehoon Lee; Brian C Helsel; Kristine N Williams; Joseph E Donnelly Journal: Contemp Clin Trials Date: 2020-09-23 Impact factor: 2.226
Authors: Ralph Jasper Mobbs; Jordan Perring; Suresh Mahendra Raj; Monish Maharaj; Nicole Kah Mun Yoong; Luke Wicent Sy; Rannulu Dineth Fonseka; Pragadesh Natarajan; Wen Jie Choy Journal: Mhealth Date: 2022-01-20
Authors: Laurie A King; Jennifer Wilhelm; Yiyi Chen; Ron Blehm; John Nutt; Zunqiu Chen; Andrea Serdar; Fay B Horak Journal: J Neurol Phys Ther Date: 2015-10 Impact factor: 3.649
Authors: Elissa Burton; Vinicius Cavalheri; Richard Adams; Colleen Oakley Browne; Petra Bovery-Spencer; Audra M Fenton; Bruce W Campbell; Keith D Hill Journal: Clin Interv Aging Date: 2015-02-09 Impact factor: 4.458